학술논문
HER-2 and topo-isomerase IIα as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide
Document Type
Article
Author
Source
In Annals of Oncology August 2001 12(8):1081-1089
Subject
Language
ISSN
0923-7534